- MCTC
Holdings Inc. is a company dedicated to research and development of
innovative infusion technologies in the fast-growing area of cannabinoids
sciences
- The
company recently announced that it is expanding on development infusion
technologies to include lesser known cannabinoids such as cannabinol (CBN)
and THC-V, which have possible applications in product that promote sleep
and control appetite
- MCTC
has thus far filed five patents and expects to file at least several
additional over the coming months
- The
company’s aim is to make the current generation of hemp extract and
cannabinoid technologies obsolete
Cannabis infusion technology developer MCTC
Holdings Inc. (OTC: MCTC), a Delaware-registered, fully reporting company,
is expanding its research beyond the four patents the company has developed
with the aim of establishing novel applications of polymeric nanoparticles of
cannabinol (CBN) and cannabinoid glycosides.
Since MCTC Holdings reorganized itself in June, the company
has focused its corporate efforts on the fast-growing cannabis industry,
specifically the development of products that build on proprietary research
into exotic cannabinoid isolation, bioenhancement of cannabinoids and polymeric
solid nanoparticles and nanofibers that can be added into consumer products and
applied through the skin.
“The polymer-based nanoparticles being developed by MCTC
significantly differ from the simple oil-in-water nanoemulsions being marketed
as interim solutions for the food and beverage industry,” the company stated in
a press release (http://ibn.fm/4zyUy).
“The polymer-based particles the Company is developing will allow for
significant loading of active ingredients and unparalleled flexibility in
creating custom cannabinoid combinations with unique performance
characteristics.”
Nanotechnology involves the study of extremely small things,
and it is a science that has been used in the food and medicine industries for
some time to help humans more effectively utilize the beneficial compounds of
food and medicine products. Nanoparticles are directly absorbed into the
bloodstream, which allows for a quicker and more effective bio-delivery of
their properties than is accomplished through digested substances (http://ibn.fm/OOIdf).
MCTC has been developing nanotechnology’s potential within
the cannabis industry, focusing on the potential of microscopic properties in
cannabidiol (CBD) by patenting an innovative edible dissolvable film, a
water-soluble form of vitamin E, a unique 3D-printed cannabinoid delivery
system for beverages, and a broad-property means of dispersing nanoparticles
and nanofibers. A fifth patent application is in process.
The company now aims to use its CBD R&D experience in
the development of uses for some of the minor cannabinoids, with CBN as the
first target. CBN is found only in small amounts and mostly results from
oxidation of the other cannabinoids in cannabis, making it difficult to obtain
and expensive as a result. But MCTC believes CBN nanoparticles have the
potential to deliver the cannabinoid’s beneficial properties in minuscule
amounts as an alternative to the volumes used currently for formulation.
MCTC is also researching the potential of cannabinoid
glycoside nanoparticles. Glycosides are molecular compounds that involve the
binding of a sugar to another compound. Many plants store chemicals in the form
of inactive glycosides, and glycosides play numerous important roles in living
organisms (http://ibn.fm/5SjLG).
MCTC states that one of its purposes in developing the
nanoparticles is for potential use in managing controlled and sustained drug
release requirements. For example, several studies indicate CBN may counteract
some of the negative effects of other cannabinoids and the creation of
particles containing both CBN and other cannabinoids, especially psychoactive
cannabinoids, could lead to new opportunities.
As part of the company’s renewed focus on the cannabis
industry, MCTC is anticipating a name change to Cannabis Global Inc. in the
near future.
For more information, visit the company’s website at www.CannabisGlobalInc.com
NOTE TO INVESTORS: The latest news and updates
relating to MCTC are available in the company’s newsroom at http://ibn.fm/MCTC
About QualityStocks
QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential. We offer several ways for investors to learn more
about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment